Skip to main content
Christine Durand, MD, Infectious Disease, Lutherville, MD

Christine Marie Durand MD


Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Join to View Full Profile
  • 10751 Falls RoadFalls Concourse Ste 412Lutherville, MD 21093

Are you Dr. Durand?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 39 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Christine Durand, MD is an infectious disease specialist in Lutherville, Maryland. She is currently licensed to practice medicine in Maryland. She is affiliated with Johns Hopkins Hospital and is an Assistant Professor of Medicine at Johns Hopkins University School of Medicine.

Education & Training

  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2006

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • 'This Medical Report Will Have Little Effect': What We Heard This Week
    'This Medical Report Will Have Little Effect': What We Heard This WeekOctober 20th, 2024
  • Kidney Transplant Noninferior from Donors with Versus Without HIV in HIV-Positive Recipients
    Kidney Transplant Noninferior from Donors with Versus Without HIV in HIV-Positive RecipientsOctober 18th, 2024
  • Study Finds HIV-to-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs from Donors Without HIV
    Study Finds HIV-to-HIV Kidney Transplants Are as Safe and Effective as Those Using Organs from Donors Without HIVOctober 16th, 2024
  • Join now to see all

Grant Support

  • Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term OutcomesJOHNS HOPKINS UNIVERSITY2023–2028
  • A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)JOHNS HOPKINS UNIVERSITY2022–2027
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver TransplantationJOHNS HOPKINS UNIVERSITY2018–2025
  • HOPE in Action: A Clinical Trial of HIV-to-HIV Liver TransplantationJOHNS HOPKINS UNIVERSITY2018–2025